TotalCardiology Letters Study

February 17, 2026 updated by: Tavis S. Campbell, University of Calgary

A Proof-of-Concept Study Evaluating a Theory-Based Motivational Letter to Increase Attendance to a One-Year Post-Cardiac Rehabilitation Risk Factor Check

The goal of this study is to see if a theory-based motivational letter can increase attendance at a one-year post-cardiac rehabilitation (CR) appointment in adults who have finished a CR program. The main question it aims to answer is:

• Can a theory-based motivational letter increase attendance at one-year follow-up appointments?

Researchers will compare participants who received the letter to those who received care as usual to see if there are any differences in attendance and risk factor management.

Participants will:

  • Get a letter approximately 6 months before their one-year follow-up or care as usual
  • Attend any appointments as usual
  • Do routine health checks during their visits

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Alberta
      • Calgary, Alberta, Canada, T2E 7C5
        • TotalCardiology Rehabilitation
      • Calgary, Alberta, Canada, T2N 1N4
        • Behavioural Medicine Lab

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults of age ≥18 years
  • Have completed the 12-week TCR program (including the 12 week final visit)
  • Have a pre-booked 1-year visit marked in their TCR patient chart

Exclusion Criteria:

  • Patient program status is listed as "discharged" or "deceased"

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Letter Group
Other: Theory-based motivational letter
A theory-based motivational letter will be mailed to patients 6 months in advance of their one-year post-CR follow-up appointment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Attendance at one-year post-CR follow-up appointment
Time Frame: From enrollment to the one-year post-CR follow-up appointment
The primary outcome will be whether participants attend their one-year post-CR risk factor assessment (assessed by binary, yes or no).
From enrollment to the one-year post-CR follow-up appointment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Demographics
Time Frame: From enrollment to the one-year post-CR follow-up appointment
Demographics (e.g. sex, gender, age, etc.) will be assessed by TotalCardiology medical chart review.
From enrollment to the one-year post-CR follow-up appointment
Clinical Factors
Time Frame: From enrollment to the one-year post-CR follow-up appointment
Cardiovascular clinical factors will be assessed by TotalCardiology medical chart review.
From enrollment to the one-year post-CR follow-up appointment
Cardiovascular Risk Factors
Time Frame: From enrollment to the one-year post-CR follow-up appointment
Cardiovascular risk factors will be assessed by TotalCardiology medical chart review.
From enrollment to the one-year post-CR follow-up appointment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Calgary

Collaborators

Total Cardiology Rehabiliation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 2, 2024

Primary Completion (Actual)

December 31, 2025

Study Completion (Actual)

December 31, 2025

Study Registration Dates

First Submitted

February 17, 2026

First Submitted That Met QC Criteria

February 17, 2026

First Posted (Actual)

February 24, 2026

Study Record Updates

Last Update Posted (Actual)

February 24, 2026

Last Update Submitted That Met QC Criteria

February 17, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • REB23-1586

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases (CVD)

Clinical Trials on Theory-based motivational letter

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe